Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
Clinical trial NCT03588936 · TERMINATED
Trial details
- NCT number
- NCT03588936
- Sponsor
- Medical College of Wisconsin
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-14
- Primary completion
- 2020-07-15
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.